Immunoinformatics Approach to Design a Novel Subunit Vaccine Against Visceral Leishmaniasis

Visceral leishmaniasis (VL) infection is mostly caused by Leishmania donovani and affects countries worldwide. Despite the need for a safe and effective vaccine against leishmaniasis due to the increased drug resistance, however, no vaccine has yet been licensed for clinical use. This study revolves...

Descripción completa

Detalles Bibliográficos
Autores principales: Lari, Alireza, Lari, Niloofar, Biabangard, Atefeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675112/
https://www.ncbi.nlm.nih.gov/pubmed/34931120
http://dx.doi.org/10.1007/s10989-021-10344-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675112/
https://www.ncbi.nlm.nih.gov/pubmed/34931120
http://dx.doi.org/10.1007/s10989-021-10344-3

Ejemplares similares